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ABSTRACT
Background: Substantial investments are being made in health  information 
 technology (HIT) based on assumptions that these systems will save costs 
through increased quality, safety and efficiency of care provision. Whilst  short-term 
 benefits have often proven difficult to demonstrate, there is increasing interest 
in achieving benefits in the medium and long term through secondary uses of 
 HIT-derived data. 
Aims: We aimed to describe the range of secondary uses of HIT-derived data in the 
international literature and identify innovative developments of particular relevance 
to UK policymakers and managers.
Methods: We searched nine electronic databases to conduct a systematic scoping 
review of the international literature and augmented this by consulting a range of 
experts in the field.
Results: Reviewers independently screened 16,806 titles, resulting in 583  eligible 
studies for inclusion. Thematic organisation of reported secondary uses was 
 validated during expert consultation (n = 23). A primary division was made between 
patient-identifiable data and datasets in which individuals were not identified. 
Secondary uses were then categorised under four domain headings of: i) research; 
ii) quality and safety of care provision; iii) financial management; and iv) healthcare 
professional education. We found that innovative developments were most 
 evident in research where, in particular, dataset linkage studies offered important 
 opportunities for exploitation. 
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BACKGROUND
Healthcare still trails behind other major industries in fully 
exploiting information and communication technologies (ICTs) 
to maximise quality, safety and efficiency in service delivery. 
It can be argued that this is partly due to the complexity of 
organising and delivering healthcare services and to the chal-
lenges of introducing standardised ICT systems across health-
care settings where these are diverse and largely autonomous 
organisations. Yet considerable effort and capital investments 
are being made in the United Kingdom (UK) national health 
services and in healthcare organisations internationally to pro-
cure and implement ICT systems, also known as eHealth or 
health information technology (HIT).1,2 Such investments have 
been justified by assumptions that routine use of HIT should 
lead to improved patient outcomes and to cost saving effi-
ciencies in service delivery, for example by streamlining care 
processes.3,4 Recent work, however, suggests that in practice 
benefits from HIT can be hard to identify, at least in the short 
term. It has, for instance, been found that some processes can 
become more time consuming for some staff during the early 
years of using a new HIT system.3,4 
Such disappointing evidence for the anticipated quick gains 
and returns on investments in HIT could potentially jeopardise 
continued spending on HIT initiatives. Unrealistic assumptions 
about the timelines for delivering benefits, for example, from 
core systems such as electronic health records and ePrescrib-
ing systems, place an emphasis on early measurable gains, 
whereas more significant advantages to healthcare and society 
might accrue in the medium to long term and then particularly 
through innovative uses of the wealth of health-related digital 
data that become available.5–9 Secondary uses of data – the 
use and re-use of clinical and administrative data other than 
for the direct clinical care of specific patients – may present the 
greater opportunity for realising benefits from HIT investments, 
with such benefits emerging more slowly. 
In 2007, the American Medical Informatics Association 
(AMIA) identified the then current areas of secondary uses 
of health-related digital data in USA settings.10 This system-
atic scoping review, part of a larger, mixed-methods inves-
tigation into maximising the safe and secure exploitation of 
HIT-derived data in the UK context, aimed to build on that 
earlier USA work in order to provide an updated, international 
framework of secondary uses. Our focus was on current and 
potential future developments of particular relevance for UK 
policymakers and health service managers. 
METHODS
We conducted a systematic scoping review. According to 
Arksey and O’Malley,11 a scoping study is a type of literature 
review that can serve to ‘map’ a field of interest; unlike a system-
atic literature review, it is unlikely to address a narrowly defined 
research question or to assess the quality of included studies. 
This approach is well suited to exploring under-researched or 
emerging fields of study, where empirical evidence is limited. 
Our systematic scoping review was guided by the six-stage 
methodological framework developed by Levac et al.12 from 
the Arksey and O’Malley’s original framework (Box 1).
Box 1 Summary of methodological guidelines for 
systematic scoping reviews, from Levac et al.11
1. Identify the research question/purpose of the scoping 
review
2. Identify relevant studies
3. Select studies
4. Chart the data
5. Collate and summarise findings
6. Consult stakeholders
Identifying relevant studies
With assistance from an experienced medical librarian, we devel-
oped, tested and modified a strategy to search the published 
literature from the beginning of 2000 to the end of 2013 in nine 
electronic databases. We searched the following databases: 
MEDLINE, EMBASE, The Cochrane Database of Systematic 
Reviews, Database of Abstracts of Reviews of Effects, The 
Cochrane Central Register of Controlled Trials, The Cochrane 
Methodology Register, The Health Technology Assessment 
Database, National Health Service (NHS) Economic Evaluation 
Database, and The National Research Register, as well as in 
LILACS, Lexis Library, and Google Scholar for grey literature. 
The terms in the first set of search terms related to HIT sys-
tems and were based on a literature search strategy previously 
employed in a systematic review of the eHealth literature.3 
Terms in the second search set related to secondary uses of 
healthcare data, drawing on the 2007 taxonomy of secondary 
uses developed by AMIA.10 (Appendix 1). Terms within groups 
were combined using the Boolean operator “OR” and the groups 
combined with the Boolean operator “AND” (Appendix 2). We 
applied no language or publication status restrictions. 
Conclusions: Distinguishing patient-identifiable data from aggregated, de-iden-
tified datasets gives greater conceptual clarity in secondary uses of HIT-derived 
data. Secondary uses research has substantial potential for realising future benefits 
through generating new medical knowledge from dataset linkage studies, develop-
ing precision medicine and enabling cross-sectoral, evidence-based policymaking 
to benefit population-level well-being. 
Keywords:  Medical informatics, health services research, systematic scoping 
review
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Ethical approval
Ethical approval was not required for the systematic scop-
ing review. The consultation phase was conducted within a 
related interview study that formed part of the larger, mixed-
methods project from which we are reporting the scoping 
review component here. We obtained ethical approval for the 
interview study from The University of Edinburgh, and each 
participant gave informed consent prior to taking part. 
RESULTS
Our search strategy identified 20,551 potentially relevant 
papers. After deduplication, 16,806 papers were included 
for initial screening; a further 15,089 papers were excluded 
because they did not meet the inclusion criteria. 1717 retained 
abstracts were reviewed, of which 1134 papers were defined 
as background papers (for example papers describing HIT 
infrastructure), resulting in 583 studies being included in the 
review. The results are presented as a Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA) 
study flow diagram, shown in Figure 1. 
Source of studies
The included studies represented a spread of developed 
countries, with the most prominent being the USA. They also 
included Canada, Australia, the UK, other European coun-
tries, Scandinavian nations and The Netherlands (Figure 2).
Secondary uses
The publications referenced a range of areas in which health-
related digital data were being used beyond supporting 
individuals’ clinical care. The scope of reported secondary 
uses included for conducting epidemiological and pharmaco-
vigilance research studies, for facilitating recruitment to ran-
domised controlled trials14–16 and for carrying out audits and 
benchmarking studies.17,18 We also found secondary uses 
being used for financial and service planning, incident track-
ing, the teaching of clinical staff and billing.19,20
The examples of secondary uses came from within a sin-
gle healthcare organisation (for example local audits), across 
healthcare settings (such as in service planning) and from 
dataset linkage studies. 
Dataset linkage research
Innovative developments were most evident in the research 
domain, with ongoing efforts in several developed coun-
tries to establish the research infrastructure for dataset link-
age  studies.21–26 For instance, researchers were able to use 
Scotland-wide routinely collected hospital admission data com-
bined with death certificate data to show that legislation to ban 
smoking in public places in Scotland was followed by a reduc-
tion in hospital admissions for childhood asthma.27 In Denmark, 
researchers also used health dataset linkage to conduct a 
nationwide seven-year study of everyone aged 18–36, using 
national registries, death certificates and primary care data to 
investigate the relative and absolute risks of sudden cardiac 
death in young Danes with a prior myocardial infarction.28 
Study selection
After initial screening by the team and removing duplicate 
publications, three researchers (AR, UN and KC) inde-
pendently checked titles and abstracts against the inclu-
sion/exclusion criteria. We included empirical studies that 
reported information about secondary uses of data held 
in core HIT systems in developed countries. Publications 
were excluded if they fell outside the scope of interest, for 
example, those reporting on technologies not associated 
with core HIT functionalities (for instance reports of speech 
recognition functionality). We excluded studies reporting 
on HIT implementations in developing countries because 
of the contextual differences between healthcare and its 
delivery in developing and developed countries. We then 
retrieved and reviewed the full texts of potentially eligible 
publications.
Charting the data
We used customised Excel forms to extract data from each 
of the full text papers eligible to be included in our review. 
The variables that were recorded by three researchers (AR, 
HS and UN) were author and year, title of the study, country 
of origin, keywords and the area of secondary uses reported, 
and if a study was deemed by the reviewer to offer an exam-
ple of a new development in secondary uses.
Collating and summarising the extracted 
data
We used a thematic, qualitative content analysis approach12,13 
to organise the various areas of secondary uses identified from 
the review into broad domains of secondary uses, resolving 
any uncertainties by discussion among the researchers who 
had charted the data and within the wider research team.
Consultation with experts
We discussed our preliminary findings with a range of 
national and international experts to seek validation of 
our thematic organisation into domains of secondary 
uses and any additional insights into innovative develop-
ments in secondary uses. These individuals were selected 
based on their involvement in activities related to using 
data held in HIT systems in the UK, with additional experts 
beyond the UK being invited from regions with an interna-
tional reputation for current work in this field. Consultees 
included policymakers, health professionals, academics 
(including researchers) and representatives of the phar-
maceutical industry, the legal profession and the third sec-
tor. We approached 28 potential consultees (declined = 1; 
no response or subsequently could not be contacted = 4), 
leading to 23 interviews with participants throughout the 
UK and in Australia, Canada and the USA. One partici-
pant subsequently withdrew consent, reporting new work-
place restrictions on giving interviews and consequently 
that audio file and transcript were deleted from our dataset. 
During the consultation stage of the scoping review, con-
sultees were asked to highlight areas illustrative of devel-
opments in secondary uses research.
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20,551 potentially relevant papers from 9
databases were identified
After de-duplication 16,806 potentially
relevant papers are included for screening
15,089 papers excluded
for not meeting review
criteria
1,717 appropriate abstracts
reviewed
1,134 papers defined as
background papers
3,745 duplications
excluded
583 papers included in this review:
• Education     7
• Finance     20
• Quality/Safety    249
• Research     307
MEDLINE: 3,070
EMBASE: 13,078
HTA: 822
NHS EED: 4
Register: 58
LexisLibrary: 2
Cochrane library: 3,495
LILACS: 5
Google Scholars: 17
The National research
Figure 1 PRISMA flow diagram
UK
Continental Europe
The Netherlands
North America
Australia
Scandinavia
other
3%5%
7%
15%
56%
7%
7%
Figure 2 Countries of origin of the papers included in the scoping review
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In addition to data linkage studies using health-related 
datasets, existing examples of studies using cross-sectoral 
data linkage included the linking of population-wide health 
and justice datasets in Western Australia to study hospitali-
sations among exprisoners during the first year after their 
release29 and seeking evidence to help plan healthy neigh-
bourhoods across the lifespan by investigating measures of 
the built environment linked to health outcomes and to self-
reported health behaviours.30
Domains of secondary uses
Overall, the majority of examples of secondary uses identi-
fied from scoping the literature could be categorised under 
the broad heading of research. Research was followed by 
a second large domain of quality and safety of care provi-
sion, which included audit. We grouped all of the studies in 
the review thematically into a total of four broad domains of 
current secondary uses: 1) research (n = 307); 2) quality and 
safety of care (n = 249); 3) financial management (n = 20); 
and 4) education (n = 7) (Figure 3). An initial long list of sec-
ondary uses generated from the scoping review, from which 
the four domains were derived, is shown in Appendix 3.
Consultation phase of scoping review
We approached 28 people (declined = 1; no response or sub-
sequently could not be contacted = 4), leading to 23 expert 
participants throughout the UK and in Australia, Canada and 
the USA. During this stage of the scoping review, consultees 
were asked to highlight areas illustrative of new developments 
in secondary uses research. They drew attention to investi-
gations into risk factors, treatments and disease outcomes 
(notably, in Scotland, diabetes-related studies), drug safety, 
and policy evaluation, service delivery and public health.31–34 
Consultees were asked to comment on the thematic 
organisation of secondary uses identified from scoping the 
literature into four domains. In addition to listing the four cur-
rent domains, it was suggested it would be helpful first to 
distinguish between secondary uses involving data contain-
ing identifiers for patients – essential for providing direct, clin-
ical care and also for some secondary uses, for instance for 
tracing individuals affected by contaminated surgical instru-
ments in crisis management – and aggregated, deidentified 
datasets (where deidentified data were also variously known 
as anonymised and pseudonymised data). Keeping that dis-
tinction to the fore was considered important for policymak-
ers and managers aiming to maximise HIT-derived benefits 
because of the potential for significant new research findings 
that were dependent on exploiting large quantities of dei-
dentified aggregated data. Confusing data with and without 
patient identifiers could negatively impact on public support 
for secondary uses. Patients’ privacy, confidentiality and con-
sent for the use and reuse of data where those data identified 
individual patients were recognised as important concerns to 
many people. 
Looking towards the future of HIT-derived data and sec-
ondary uses, consultees spoke of expanding the range of 
health-related datasets that were available to researchers 
in the UK to include general practice, imaging, genomic and 
biotech data, and datasets from non-health sectors such as 
education, housing and justice. In the UK, the potential for 
the Farr Institute35 to be working in close collaboration with 
the Administrative Data Research Network (ADRN)36 was 
highlighted as a positive step for developing cross-sectoral 
research work. It was believed that population well-being 
should benefit from cross-sectoral dataset linkage research 
with such studies generating an evidence base to underpin 
UK policy decisions and policy evaluations beyond specifi-
cally health policy. However, this could not be achieved with-
out national workforce planning and training in order to have 
sufficient staff with the necessary range of technical and 
methodological skills to work in data linkage.
In addition to envisaged developments in – and longer-
term benefits from – dataset linkage studies, progress in nat-
ural language processing software should increasingly allow 
researchers to take advantage of uncoded text in electronic 
health records. Those data and patient reported measures 
both would add to the digital data likely to become more 
widely available for secondary use research in the future.
DISCUSSION
We searched nine international electronic databases, 
screened 16,806 titles and found 583 eligible studies. The 
systematic scoping review identified secondary uses of digi-
tised health-related data in the domains of research (the larg-
est category), quality and safety of service provision, financial 
management, and education. Innovations in secondary uses 
were most evident in the research domain with the devel-
opment of dataset linkage studies. Consultation with experts 
confirmed that research linking datasets – both linking health 
datasets with each other and linking between health and 
datasets from other sectors – would in their opinion continue 
to expand and to deliver health-related and wider societal 
benefits from investments in HIT systems.
3% 1%
Quality and safety of care
Education
Research
Financial management
53%43%
Figure 3  Domains of secondary uses identified in the 
scoping review
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processes, time and a dose of reality. Journal of the American 
Medical Informatics Association 2012;307:2255–2255. 
 6. Avery A, Rodgers S, Cantrill JA, Armstrong S, Elliott R, Howard 
R et al. PINCER trial: a cluster randomized trial comparing 
the effectiveness and cost-effectiveness of a pharmacist-led 
IT-based intervention with simple feedback in reducing rates of 
clinically important errors in medicines management in general 
practices. Lancet 2012;379(9823):p1310–1319; http://dx.doi.
org/10.1016/S0140-6736(11)61817-5.
 7. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson 
J, Minhas R, Sheikh A et al. Predicting cardiovascular 
risk in England and Wales: prospective derivation and 
 validation of QRISK2. BMJ 2008;336:1475–1482. http://
dx.doi.org/10.1136/bmj.39609.449676.25. PMid:18573856; 
PMCid:PMC2440904.
 8. Lidegaard Ø, Løkkegaard E, Jensen A, Skovlund CW and 
Keiding N. Thrombotic stroke and myocardial infarction with 
hormonal contraception. New England Journal of Medicine 
2012;366:2257–66. http://dx.doi.org/10.1056/NEJMoa1111840. 
PMid:22693997.
This is the first UK-focused systematic scoping review 
of secondary uses, updating the previous work in this area 
undertaken elsewhere.10 The publicly funded NHS in the UK 
and the availability of national and regional datasets contrib-
ute to a UK-specific context for secondary uses of health-
related digital data and likely offer particularly strong potential 
for innovative research that exploits dataset linkages. 
While the UK context and a growing emphasis on data-
set linkage studies are quite distinctive, the range of areas 
of secondary uses identified in our literature review is sim-
ilar to the areas of secondary uses previously identified 
despite the passing of time since that earlier work from the 
USA. 10 Domains for secondary uses of health-related digi-
tal data may have reached a level of stability, at least for 
the foreseeable future. The more dynamic aspects appear 
likely to be contextual factors, for example national and 
international legislation controlling personal data, and fur-
ther developments within a given secondary use domain, 
such as within the research domain. Understanding where 
the most potential for developing secondary uses cur-
rently lies and appreciating the importance of distinguish-
ing clearly between data that identify patients and data 
that are aggregated and deidentified are a resource for 
UK policymakers who are developing plans and policies 
related to secondary uses of health-related digital data and 
for all those aiming to maximise returns from investing in 
HIT systems.
Strengths and limitations 
The main strengths of our scoping review are the systematic 
database searching, the broad inclusion criteria and including 
an expert consultation stage in a thorough methodological 
approach to scoping our topic. The work is also timely in view 
of substantial funding in the UK to support the Farr Institute 
and the ADRN and collaborative working between the two, 
which is likely to enhance the potential for developing cross-
sectoral linkage studies.35,36 A limitation of this literature 
review is that it may have missed routine secondary uses of 
healthcare data for management, planning, finance and audit 
purposes, which are taking place within healthcare settings 
but which would not necessarily be published in the literature. 
CONCLUSIONS
Distinguishing between patient-identifiable data and deidenti-
fied datasets can help improve conceptual clarity with respect 
to secondary use policy and planning deliberations in the UK. 
Innovative secondary uses of data for research purposes hold 
the promise of new medical knowledge derived from health 
dataset linkage studies, advances in personalised precision 
medicine and the advent of cross-sectoral evidence-based 
policymaking and policy evaluations. In developed nations, 
domain headings for the various secondary uses of health-
related digital data may have attained a level of stability for 
the foreseeable future and hence only require future updating 
scoping reviews at longer intervals.
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Search strategy 1, MEDLINE format
 1.  (eHealth or e health or e-health).mp.
 2. Telemedicine/
 3. Telehealth.mp.
 4. Telehealthcare.mp.
 5. Telecare.mp.
 6.  Electronic Prescribing or ePrescribing.mp  
or e-prescribing.mp.
 7. Electronic prescri*.mp.
 8.  Hospital information systems or information systems 
or medical records systems, computerised/
 9.  Health information technology.mp. or Medical 
Informatics/
10. Medical information system*.mp.
11. Health information system*.mp.
12. Health informatics.mp.
13.  Management information systems or management 
information system*.mp.
14. Integrated advanced information management.mp.
15. Electronic health records
16. Computerised patient record*.mp.
17.  Personal health record*.mp. or health records, 
personal/
18.  Decision making, computer-assisted/ or decision 
support systems, management/ or decision support 
techniques/ or decision support systems, clinical/
19. Decision support system*.mp. 
20. Computerised decision support.mp.
21. Computerised order entry.mp.
22. Electronic patient record.mp.
23. Computerised decision support system*.mp.
24.  Medical order entry systems or medical records 
systems, computerised/
25. Computerised physician order entry.mp.
26. Computerised physician order entry system*.mp.
27. Computerised provider order entry.mp.
28. (Picture archiving and communication system*).mp.
29. or/1-28
30. Public health/
31. Public health informatics
32. Secondary Use*.mp. 
33. (quality management and analysis system*).mp.
34. Quality improvement.mp. or quality improvement
35.  (Quality control, healthcare or quality control, health 
care or quality control or healthcare).mp.
36.  (Quality indicator*, healthcare or quality indicator*, 
health care or quality indicator*, health-care).mp.
37. Risk management/
38. Data mining/
39. Data repositor*.mp.
40. Disease regist*.mp. 
41. Pharmacovigilance/
42. e-Science.mp.
43. Service design.mp.
44. Service re-design.mp.
45. Commission*.mp. 
46. Disease surveillance.mp.
47. Health services research/
48. Health service monitoring.mp.
49. Quality Assurance, Health Care/
50. Health surveillance.mp.
51. Epidemiology/
52. Clinical Coding/
53. (Clinical audit or medical audit).mp. 
54. Data linkage.mp.
55. Finance*.mp.
56. or/30-55
57. 29 and 56
58. Limit 57 to yr=”2000-current”
59.  advertisements/ or animation/ or architectural 
drawings/ or bibliography/ or biography/ or book 
illustrations/ or bookplates/ or charts/ or comment/  
or letter/ or news/ or patient education handout/ 
or published erratum/ or “retraction of publication”/
60. 58 not 59
AppENDIx 1
AppENDIx 2
 Search strategy 2, free-field format
(eHealth or e health or e-health or telemedicine or telehealth or telecare or telehealthcare or electronic prescri* or 
e-prescribing or eprescribing or health information technology or medical informatics or medical information system* 
or health information system* or health informatics or computerised medical records system* or hospital information 
system* or management information system* or electronic health record* or computerised patient record* or personal 
health record* or decision support system* or clinical decision support system* or computerised decision support or 
computerised order entry or electronic patient record* or medical order entry system* or computerised physician order 
entry system* or computerised provider order entry or picture archiving and communication system*)
AND:
(Public health or public health informatics or secondary use* or quality management and analysis system* or quality 
improvement or quality of health care or quality of healthcare or health care quality control or healthcare quality control 
or health care quality indicator* or healthcare quality indicator* or risk management or data mining or data repository or 
disease regist* or pharmacovigilance or e-science or service design or commission* or disease surveillance or health 
service* research or health service* monitoring or health care quality assurance or healthcare quality assurance or health 
surveillance or epidemiology or clinical coding or clinical audit or medical audit or data linkage or finances)
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AppENDIx 3
Long list of secondary uses identified from scoping review
Audit (e.g. diabetes care per guidelines; statin use; screening uptake)
Bio surveillance for disease outbreaks
Cause of death status for policy/planning in low to middle income countries (e.g. Ramatige 2012)
Clinical tool development (e.g. mammography images)
Clinical workflow templates
Communication between specialists, payers and providers, etc.
Court reports on defendants
Crisis/risk/disaster management; strategic decision making for data mining–commercial text mining tools for data mining–
compliance patterns; Decision Support development (e.g. toxicology)
Decreasing costs by reducing medical errors, duplication of services Development of integrated care pathways Disease 
profiling
Disease registries (e.g. stroke, lupus)
Disease surveillance
Education (teaching medical students, healthcare professionals, pharmacists, etc.)
Epidemiology
Finance–billing
Finance–cost benefit analyses
Finance–performance based reimbursement
Geographical mapping–for healthcare and policy
Health literacy and empowerment; evidence developmen
Healthcare safety and guality
Return on investment
HITs–a platfbrm/fbundation for strategic guidelines/next generation comparative effectiveness research in real world 
settings Hospital readmission risk calculation (e.g. heart failure)
Human phenome database (dermatology) (leaming/education and research)
Identifying and targeting at-risk patient populations Immigrants/healthcare Improvement of data standards Incident 
analysis (radiotherapy)
Indicator development
Infectious disease/disaster management
Integration of clinical care and administrative data; linkage of data; data mining management/monitoring outcome tracking
Patient self-management and self-efficacy; personalised medicine performance indicators (e.g. surgery)
Performance monitoring
Pharmacovigilance/pharmacoepidemiology (adverse events)
Predictive models for disease outbreaks (e.g. measles)
Preventative care and health promotion Prognostic marker
Prognostic modelling e.g. coronary artery disease (CALIBER study, Rapsomaniki, Shah et al., 2012)
Public health records
Public health surveillance
Quality control of services (e.g. ECT)
Quality improvement (Comparative effectiveness research, clinical decision support and disease surveillance)
Quality measurement
Race/ethnicity/sex differences for risk (e.g. REGARD)
Reducing conventional administrative work for intractable/notifiable diseases Reporting and monitoring Research–Case 
control studies Research–Cohort studies
Research–disease markers/neurodegenerative disorders (neuGRID, Redolfi et al., 2009, research–distributed virtual 
global lab (Suominen, 2012)
Research–Electronic Health Records for Clinical Research collaboration; see Thomson et al., 2012
Research–Genetic research/disease traits
Research–identifying potential research participants from particular populations Research–observational epidemiological 
studies (e.g. Rochester Epidemiology Project)
Research–pathology
Research–prescription abandonment/treatment adherence (e.g. Shrank, 2010)
Research–Rare disorders research (ORPHANET)
Research/Natural Language Processing (NLP), e.g. to assess smoking Resource allocation
Scales validation (e.g. asthma control scale)
Service planning
Standards development (e.g. for EHRs)
Toxicovigilance–Rapid Alert System for Chemicals database tracking of trends and prediction of patterns
